STOCK TITAN

LXEO (NASDAQ: LXEO) insider resale notice for 11,374 vested shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

LXEO Form 144 filing reports planned resale of 11,374 common shares tied to restricted stock vesting. The filing lists a restricted stock vesting transaction dated 02/17/2026 showing 11,374 shares as "Securities To Be Sold" and notes prior sales of 1,127 shares on 11/18/2025.

Positive

  • None.

Negative

  • None.

Insights

Routine resale notice for vested restricted shares; administrative disclosure under Rule 144.

This filing lists 11,374 common shares associated with a restricted stock vesting event dated 02/17/2026, identified as "Securities To Be Sold." The submission follows standard resale-reporting practice under Rule 144.

Cash‑flow treatment is not stated; prior sales of 1,127 shares on 11/18/2025 are disclosed. Subsequent trading activity will depend on holder decisions and compliance with transfer restrictions.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does LXEO's Form 144 disclose about the shares?

It discloses a planned resale of 11,374 common shares tied to restricted stock vesting on 02/17/2026. The filing also reports prior sales of 1,127 shares on 11/18/2025, reflecting recent insider disposition activity.

Who is named in the LXEO Form 144 filing?

The filing names Richard N. Townsend and a brokerage address for Fidelity Brokerage Services LLC. It associates the resale with restricted stock vesting and lists the brokerage details provided in the notice.

Does the Form 144 state how the proceeds will be used?

The filing does not state a use of proceeds for the resale of shares. It records the number of shares tied to vesting and prior sales but provides no proceeds allocation information.

When were the restricted shares vested according to the filing?

The restricted stock vesting date is shown as 02/17/2026 for the 11,374 common shares listed as to be sold. That vesting date is the basis for the resale notice.

Does the Form 144 indicate recent insider sales for LXEO?

Yes; it lists a past sale of 1,127 shares dated 11/18/2025, indicating prior insider disposition within the three‑month reporting window.
Lexeo Therapeutics Inc

NASDAQ:LXEO

LXEO Rankings

LXEO Latest News

LXEO Latest SEC Filings

LXEO Stock Data

457.63M
67.58M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
NEW YORK